title: Why are promising new drugs for dying patients still out of reach?
authors.forename: Carol
authors.initials: C
authors.lastname: Peckham
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005260:Female; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006801:Humans; D000077341:Lapatinib; D011799:Quinazolines / Q000627:therapeutic use*; D013727:Terminal Care / Q000331:legislation & jurisprudence* / Q000379:methods; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077341:Lapatinib